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Abstract 
Background: Gastrodia and Uncaria decoction (tianma gouteng yin) is commonly used in Chinese medicine to treat 
cerebral ischemia. The aim of this study was to investigate the neuroprotective effects of a water extract (GUW) of 
Gastrodia elata (tianma; GE) and Uncaria rhynchophylla (gouteng; UR) against ischemic insult using oxygen‑glucose‑
deprived neuronal differentiated PC12 cells and rats subjected to middle cerebral artery occlusion (MCAO).
Methods: GUW was prepared by boiling raw GE and UR in water, followed by the lyophilization of the resulting 
extract. Neuronal differentiated PC12 cells were subjected to oxygen‑glucose deprivation with or without GUW. The 
neuroprotective effects of GUW were compared with those of the corresponding GE and UR extracts to tease apart 
the effects of the different herbs. The synergistic effect of GE and UR in GUW was measured using a modified ver‑
sion of Burgi’s formulae. The neuroprotective mechanisms via Nrf2 and anti‑apoptotic pathways were investigated 
using real time PCR and enzyme activity assays. The neuroprotective effects of GUW were studied in vivo using a rat 
MCAO model. Neurofunctional outcome and brain infarct volume we assessed. H&E staining, cresyl violet staining and 
immunohistochemistry were performed to assess the histological outcome.
Results: The results of lactate dehydrogenase assay showed that GUW protected cells in a concentration‑dependent 
manner (P < 0.001). Moreover, the neuroprotective effects of GUW were greater than those of GE + UR (P = 0.018). 
Burgi’s formula showed that the herbs in GUW acted synergistically to protect cells from ischemic injury. GUW signifi‑
cantly upregulated Bcl‑2 expression (P = 0.0130) and reduced caspase‑3 activity by 60 % (P < 0.001). GUW upregu‑
lated Nrf‑2 expression (P = 0.0066) and the antioxidant response element pathway genes. The infarct volume was 
reduced by 55 % at day 7 of reperfusion (P < 0.001), and significant improvements were observed in the neurological 
deficit score and beam‑walking test at 7 days (P < 0.001). H&E and cresyl violet staining revealed higher tissue integrity 
in the GUW treatment group compared with MCAO rats.
Conclusion: GUW modulated the antioxidant system and antiapoptotic genes in oxygen‑glucose deprived neuronal 
differentiated PC12 cells and MCAO sprague–dawley rats.
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(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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Background
Stroke is the third major cause of death in the world, 
with more than 80 % of strokes being caused by cerebral 
ischemia [1]. Recombinant plasminogen activator is cur-
rently the only FDA-approved drug for the treatment 
of acute stroke, but its effectiveness has been limited by 
its small therapeutic window and severe complications 
[2–4]. Moreover, the therapeutic dose of this drug is too 
low to affect the cellular mechanisms responsible for 
neuroprotection.
The reactive oxygen species (ROS) generated dur-
ing ischemia are one of the major contributing factors 
to neuronal cell death [5]. Oxidative stress occurs when 
the rate at which ROS are cleared by the intracellular 
anti-oxidant system is slower than the rate at which they 
are produced. ROS can oxidize a variety of intracellular 
molecules such as DNA and lipids, eventually leading to 
apoptotic cell death [5]. Neurons are more susceptible to 
oxidative damage than most other cells because of their 
high metabolic rate and low expression levels of antioxi-
dant enzymes [6].
The increase of antioxidant enzymes expression and 
activity might attenuate cellular ischemic injury. Nuclear 
factor erythroid 2-related factor 2 (Nrf-2) is a tran-
scription factor that acts on the cis-acting antioxidant 
regulating element (ARE) to regulate the expression of 
antioxidant enzymes, including superoxide dismutase 
(SOD) and glutathione peroxidase (GPx) [7, 8]. The 
upregulation of Nrf-2 and antioxidant enzymes effec-
tively protected neurons from ischemic injury, improving 
histological outcomes and sensorimotor functioning of 
ischemic rats [9, 10]. Conversely, protein disulfide isomer-
ase (PDI) activity prevents DNA fragmentation and cell 
death in hippocampal neurons from ischemic rats [11].
Chinese medicine has been used extensively to treat a 
variety of different brain diseases, and Gastrodia Uncaria 
decoction (tianma gouteng yin), in particular, is com-
monly used for treating cerebral ischemia and brain-
related disease [12–16]. The main herbal components of 
Gastrodia Uncaria decoction include Gastrodia elata 
(Tianma; GE) and Uncaria rhynchophylla (Gouteng; 
UR). Several studies have demonstrated the prevention 
of ischemia-induced apoptosis by GE extracts and its 
active components [17–19]. Furthermore, the methanolic 
extracts of UR have been reported to exhibit neuropro-
tective effects against global cerebral ischemia in rats 
[20–22].
The aim of this study was to investigate the effects of 
the water extract of Gastrodia elata and Uncaria rhyn-
chophylla (GUW) and its antioxidative mechanisms on 
oxygen-glucose deprived (OGD) neuronal differentiated 




All the chemicals used in this study were purchased 
from Sigma-Aldrich (St. Louis, MO, USA) unless speci-
fied otherwise. Cell culture media and supplements were 
obtained from Life Technologies (Grand Island, NY, 
USA).
Extraction methods
Crude GE and UR were purchased from Zhixin Medicine 
Health Co. (Guangdong, China). The herbal extracts were 
authenticated by Dr. Zheng Ling at the Institute of Chi-
nese Medicine, The Chinese University of Hong Kong, 
based on the methods described in the 2010 edition 
of the Chinese Pharmacopoeia (Additional file  1) [23]. 
Voucher specimens of GE (Specimen No: 2010–3294) 
and UR (Specimen No: 2010–3295) were kept at the Insti-
tute of Chinese Medicine Museum, The Chinese Univer-
sity of Hong Kong. The GUW extract was prepared based 
on the boiling procedure used for preparing GE and UR 
in Gastrodia and Uncaria decoction [24]. Briefly, GE 
(107.1 g) was immersed in distilled water (2.5 L) for 1 h 
and boiled for 45 min. UR (142.9 g) was then added, and 
the resulting mixture was heated at reflux for 15  min. 
The mixture was then cooled to room temperature and 
filtered, and the resulting filtrate was rotary evaporated 
and lyophilized using a BÜCHI Rotavapor R-220 (Flawil, 
Switzerland) to give a powder (Fig. 1a).
Individual extracts GE and UR were prepared sepa-
rately by immersing the individual herbs in water in a 
1:10 (w/v) ratio for 1  h, and then heating the resulting 
mixtures at reflux for 1 h. The mixtures were then filtered 
to give the water-soluble fractions, and stored at room 
temperature for later use. This process was repeated for 
the herbal residues of GE and UR. Both fractions were 
pooled together to make the individual GE (Fig. 1b) and 
UR (Fig.  1c) water-soluble fractions. These water-solu-
ble fractions were subsequently converted into powders 
using the methods described above.
Cell line
PC12 cells (ATCC, Manassas, VA, USA) were grown in 
RPMI 1640 culture medium supplemented with 10  % 
horse serum, 5 % FBS and 100 U/mL penicillin G sodium. 
The cultures were maintained at 37  °C under 5  % CO2. 
The PC12 cells were pre-treated with nerve growth factor 
7S (Millipore, Billerica, MA, USA) to obtain neuron-like 
cells [25].
Cell viability measurements by MTT assay
Cell viability was assessed by using a 3-(4,5-dimethythia-
zol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. 
Briefly, PC12 cells were seeded onto 96-well plates and 
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incubated at 37 °C under 5 % CO2 for 24 h. The cells were 
treated with GE, UR or GUW extracts at concentrations 
in the range of 0–4000  μg/mL, and the resulting mix-
tures were incubated for 24 h. The cells were then treated 
with 0.5 mg/ml MTT and incubated at 37 °C under 5 % 
CO2 for 4 h. The medium was carefully aspirated and the 
remaining formazan crystals in each well were dissolved 
in dimethylsulfoxide (10 mL). The absorbance character-
istics of the formazan solutions in each well were read at 
490 nm using a μQuant plate reader (BioTek, Winooski, 
VT, USA). The relationship between the extract concen-
tration and cell viability was visually determined. The 
pharmaceutical relationship between the GE and UR in 
GUW was calculated using a modified version of Burgi’s 
formula [26], as follow:
Ex: effectiveness of herbal extract x. For this formula, 
q < 0.85 indicates that the two drugs in question are act-
ing in an antagonistic manner, whereas q > 1.15 indicates 
that the two drugs are acting in a synergistic manner. Val-
ues in between these limits (i.e., 0.85 < q < 1.15) indicate 
that the effects of the two herbs are additive.
The effect of oxygen‑glucose deprivation on PC12 cells
PC12 cells were seeded at a density of 1.5 × 104 cells/well 
in poly-d-lysine-coated 6-well culture plates, and grown 
in RPMI 1640 culture medium supplemented with 10 % 
horse serum, 5 % FBS and 100 U/mL penicillin G sodium. 
After 24  h of incubation, neural differentiation was 
induced by the addition of a 50 ng/mL solution of nerve 
growth factor 7.0S (Millipore, Billerica, MA, USA) in 
RPMI 1640 culture medium containing 1 % horse serum 
and 0.5  % FBS. The cells were differentiated for 6  days 
q =
EGE+UR
EGE + EUR − EGE × EUR
and the differentiation medium was changed on alternate 
days. Oxygen-glucose deprivation (OGD) was applied 
on neural differentiated PC12 cells, as reported previ-
ously [27]. PC12 cells were cultured with glucose-free 
RPMI 1640 in an air-tight hypoxia chamber (STEMCELL 
Technologies Inc., Vancouver, Canada). Experimental 
groups were defined as follows: control, OGD, GUW, 
GE, UR and GE + UR. GUW was added to the different 
groups at concentrations of 1000, 2000 and 4000 μg/mL. 
Unless specified otherwise, the GUW treatment group 
was treated with 2000 μg/mL of GUW. The chamber was 
filled with anoxia gas composed of 95 % N2/5 % CO2 for 
30 min at a flow rate of 3 L/min and the cells were then 
incubated for 8 h at 37  °C to simulate ischemia. For the 
control group, the cell cultures were subjected to the 
experimental procedures described above using normal 
RPMI 1640 as the culture medium and PBS as a vehicle, 
followed by incubation under normoxic conditions.
Cytotoxicity assay
Cell death was measured after OGD based on the 
amount of lactate dehydrogenase (LDH) leaked into the 
culture medium using an LDH cytotoxicity detection 
kit (TaKaRa, Otsu, Japan), according to manufacturer’s 
instructions.
Flow cytometry analysis of ROS
Intracellular ROS production was detected using a 
dichloro-dihydro-fluorescein diacetate (DCFH-DA) 
assay [28]. Briefly, 10  μM DCFH-DA was added to the 
PC12 cells after OGD, and the cells were then incubated 
at 37 °C for 30 min in the dark. Fluorescent signals were 
detected by flow cytometry using a FACSCanto™ II sys-
tem (Becton–Dickinson, Franklin Lakes, NJ, USA), as 
reported previously [29]. The results were expressed as 
Fig. 1 Extraction protocols of a Gastrodia elata and Uncaria rhynchophylla water extract (GUW), b Gastrodia elata water extract (GE) and c Uncaria 
rhynchophylla water extract (UR)
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the relative percentage of DCF-fluorescence in the target 
groups compared with the cells in the control group.
Real‑time polymerase chain reaction (RT‑PCR)
Total mRNA was prepared using the Trizol reagent (Inv-
itrogen Life Technologies, Carlsbad, CA, USA) according 
to manufacturer’s instructions. cDNA was synthesized 
using the Promega Improm II Reverse Transcription 
System (Promega, Madison, Wi, USA) according to the 
manufacturer’s instructions. RT-PCR experiments were 
conducted at a final volume of 10  μL containing 5  μL 
of 2× SYBR® Green I master mix (BIO-RAD, Hercu-
les, CA, USA), 0.5  μL of forward and reverse primers, 
and 1.0 μL of cDNA diluted in 3 μL of DEPC H2O. The 
nucleotide sequences of the primers used in this experi-
ment were as follows: (1) PDI, forward 5′-TCTGGA 
GGAGGAGGACAAC-3′, reverse 5′- TGGAAAACACA 
TCGCTATT-3′; (2) Bcl-2, forward 5′-ATACCTGGGCC 
ACAAGTGAG-3′, reverse 5′-TGATTTGACCATTTGCC 
TGA-3′; (3) Nrf-2, forward 5′-GAGACGGCCATGACTG 
AT-3′, reverse 5′-GTGAGGGGATCGATGAGTAA-3′; 
and (4) β-actin, forward 5′-GAGGCCCCTCTGAACCCT 
AA-3′, reverse 5′-ACCAGAGGCATACAGGGACAA-3′. 
A comparative CT method was used to compare the fold 
difference in the expression of these systems relative to 
the control.
Superoxide dismutase (SOD) assay
The SOD activity in the PC12 cells after OGD was meas-
ured using a SOD assay kit (Cayman Chemical, Ann 
Arbor, MI, USA). Tetrazolium salt, xanthine oxidase 
and cell lysate were added to a 96-well plate. The OD540 
value of the formazan produced was measured by a fluo-
rescent microplate reader (FLUOstar OPTIMA, BMG 
LABTECH, Ortenberg, Germany). The results of these 
experiments were expressed as the relative percentage of 
SOD activity of each sample compared with the control.
Glutathione peroxidase assay
The GPx levels in the PC12 cells after OGD were meas-
ured using a Glutathione Peroxidase assay kit (Cayman 
Chemical) according to manufacturer’s instructions. The 
activity of GPx was estimated by measuring the opti-
cal density at 340  nm (OD340) using a Quant system 
(BioTek).
Catalase assay
The catalase activity of the PC12 cells was measured after 
OGD and the subsequent drug treatment processes using 
a catalase fluorometric detection kit (Enzo Life Sciences, 
Farmingdale, NY, USA), following the manufacturer’s 
instructions. The optical density at 595  nm (OD595) of 
resorufin was recorded. The results were expressed as 
the relative percentage of catalase activity of each sample 
compared with the control cells.
Caspase‑3 assay
After OGD, the PC12 cells were lysed with lysis buffer 
(Thermo Scientific, Waltham, MA, USA). Following two 
freeze–thaw cycles, the cell lysates were centrifuged at 
21,500×g (Heraeus Multifuge 1S-R with Microliter Rotor, 
Thermo Scientific) for 3  min at 4  °C. The supernatants 
were subsequently collected and stored at –80 °C prior to 
being analyzed. The caspase-3 activity of the lysates was 
measured using a caspase-3 colorimetric protease assay 
kit (Thermo Scientific). The results were expressed as the 
relative percentage of caspase-3 activity of each sample 
compared with the control cells.
Animals
Male Sprague–Dawley rats, weighing 260–280  g, were 
housed in cages (45 × 30 × 20 cm3) on 12-h light/dark 
cycle with ad  libitum access to chow and water. The 
animal studies were performed following the ARRIVE 
guideline (Additional file 2). All of the experimental ani-
mal procedures used in this study were conducted with 
the approval of the Ethics Committee of the Chinese Uni-
versity of Hong Kong (AEEC ref number: 11/068/MIS-5) 
(Additional files 3, 4, 5).
Middle cerebral artery occlusion (MCAO)
Rats were arbitrarily divided into three groups: GUW 
treatment, Control and Sham groups. After MCAO or a 
sham operation, the rats in the control and sham groups 
were orally administered with distilled water, whereas 
the rats in the GUW treatment group were administered 
with 288.6 mg/kg GUW once daily by oral gavage using 
an intragastric tube for 7 consecutive days.
Sprague–Dawley rats were intraperitoneally anesthe-
tized with 400  mg/kg of chloral hydrate (VWR Interna-
tional Ltd, Poole, England). The cerebral blood flow (CBF) 
in these animals was intraoperatively monitored by laser 
Doppler flowmetery (PeriFlux System 5000, Perimed AB, 
Stockholm, Sweden). The probe holder (Probe holder 
PH07-6, Perimed AB) was located at the right cerebrum 
at 1 mm posterior and 2 mm lateral to the bregma above 
the skull. Briefly, the external carotid artery (ECA) and 
its branches were isolated and ligated. A round tip 4-0 
nylon suture was inserted into the internal carotid artery 
(ICA) through the opening at the ECA and advanced to 
the anterior cerebral artery to occlude the middle cerebral 
artery (MCA). Once the MCA was occluded, the CBF was 
reduced by 60 %. After 2 h of occlusion-induced ischemia, 
reperfusion was allowed by the gentle removal of the 
nylon filament. For the sham rats, the left CCA and ECA 
were exposed without inserting the filament into the ICA.
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Infarct volume assessment
Brain infarct volume was quantified by 2,3,5-triph-
enyltetrazolium chloride (TTC) staining [30, 31]. Rats 
were euthanized with an overdose of pentobarbital at 
7  days post-operation. The brains of the rats were har-
vested and cut into slices of 2 mm in thickness. The fresh 
brain slices were immersed in 2 % TTC solution in PBS 
for 20 min at 37  °C and their images were subsequently 
captured using an Epson Perfection 1260 desktop scan-
ner (Seiko Epson Corporation, Nagano, Japan) at a res-
olution of 600 dpi. The area of the white infarct region 
was then analyzed using Adobe Photoshop CS4 Extended 
Version 11.0.1 (Adobe Systems Inc., San Jose, CA, USA). 
The infarct volume of a slice was calculated using the fol-
lowing equation:
The total infarct volume was calculated by summing up 
the infarct volumes of the different slices.
Cresyl violet staining
At the end of the experiment at day 7, the animals were 
anesthetized and their brains were perfused transcardi-
ally with phosphate buffered saline, followed by 4 % para-
formaldehyde. The brains were subsequently excised, 
embedded with paraffin wax and cut coronally into slices 
of 6-µm thickness. These sections were then stained with 
0.1 % cresyl violet for 10 min.
Immunohistochemistry
The expression levels of Nrf-2 and Bcl-2 at the penum-
bra of the rats were examined by immunohistochemis-
try. At 7 days after MCAO, the rats were euthanized and 
their brains were harvested and cut into slices of 6-µm 
thickness, as above mentioned. These sections were then 
blocked with FBS containing 10  % goat serum and 1  % 
BSA, and incubated with rabbit polyclonal anti-Nrf-2 
(1:200; Abcam, Cambridge, UK) and rabbit polyclonal 
anti-Bcl-2 (1:400; Abcam) overnight at 4  °C. The slices 
were then washed with PBS and incubated with Alexa 
Fluor® 555 Goat Anti-Rabbit IgG (H  +  L) (Invitrogen 
Life Technologies) for 1  h with dilutions of 1:400 and 
1:800 for binding on anti-Nrf-2 and anti-Bcl-2, respec-
tively. The slices were then washed with PBS and counter-
stained with DAPI. Fluorescence images were captured 
with ApoTome.2 system (Carl Zeiss AG, Jena, Germany).
Neurological deficit score
Neurological deficit score (NDS) was performed using 
a modified Bederson’s scoring system to assess the diag-
nosis and prognosis of GUW treatment on cerebral 
ischemia [32]. NDS 1: Rats showing contralateral limb 
Infarct volume = Infarct area of the slice
× thickness of the slice (2mm)
flexion (to the left limbs). NDS 2: Rats showing decreased 
resistance to lateral push to the left. NDS 3: Rats showing 
contralateral circling, i.e., circling to the left only. NDS 
4: Rats showing spontaneous circling. The NDSs were 
measured at 1, 2, 3, 5 and 7 days after the MCAO.
Beam‑walking test
A beam-walking test was applied to assess the motor coor-
dination and balance control of the forelimbs and hind 
limbs of rats treated with the different extracts to evalu-
ate their motor functional recovery after ischemia [33, 
34]. The experimental animals were trained to complete 
a beam-walking test 3 days before undergoing MCAO to 
take baseline measurements, which involved them travers-
ing an elevated narrow beam (2.5 × 120 cm, 80 cm above 
the floor) [35]. During the training days (2 days), the rats 
required less than 10  s to cross the beam. The rats were 
motivated to cross the beam by placing their home cage at 
the opposite end of the training stage. The rats were given 
90 s to cross the walkway to their home cage. Performance 
was assessed by recording the mean latency of three trials 
to walk along the beam. This beam-walking test was per-
formed at 1, 2, 3, 5 and 7 days after MCAO.
Statistical analysis
All data have been presented as the mean values ±  SD. 
Student’s t test and one way ANOVA, followed by Dun-
nett’s multiple comparison test (GraphPad Prism 5.0 
software; San Diego, CA, USA), were used for the statisti-
cal analysis. Statistical significance was taken as P < 0.05.
Results
Cell viability measurements by MTT assay
An MTT assay was used to determine the optimal con-
centration of each extract to be used on the PC12 cells. 
Fig. 2 Cell response curve of various Gastrodia elata and Uncaria 
rhynchophylla extracts. The extracts of GUW and GE did not demon‑
strate toxicity to PC12 cells even at high concentration of 4000 µg/
mL, whereas the UR extract showed toxicity to PC12 cells at concen‑
trations higher than 1000 µg/mL vs control by one way ANOVA, post 
hoc Dunnett’s test (n = 4)
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The GUW and GE extracts were found to be non-toxic to 
PC12 cells at concentrations below 4000 µg/mL (Fig. 2). 
However, the UR extract exhibited significant toxicity at 
concentrations greater than 2000 μg/mL (P < 0.001) and 
gave an IC50 value of 2557 μg/mL.
Effect of GUW on the morphological characteristics of PC12 
cells following OGD
Neurite extensions were found in the nerve growth factor 
(NGF)-treated PC12 cells in the control group (Fig. 3a). 
In general, the cells in the OGD group become globular 
in shape with shorter neurite protrusions (Fig. 3b). GUW 
treatment did not lead to any discernible differences in 
the neuronal morphology and neurite branches of these 
cells (Fig. 3c).
GUW extracts against OGD‑induced cell injury
PC12 cells showed 70 % cell death after the OGD treatment 
process. The treatment of the cells with GUW provided 
them with significant protection from OGD-induced cell 
death (P < 0.001, Fig. 3d). Moreover, GUW exhibited neu-
roprotective effects in a concentration-dependent manner.
Fig. 3 Morphologies of NGF‑differentiated PC12 cells under OGD with or without GUW treatment. a NGF‑treated PC12 cells differentiated with 
neurite extentions without OGD treatment. b After OGD, cell bodies shrank with a loss of neurite outgrowth. c PC12 cells retained neuronal mor‑
phology with GUW treatment. (Mag. 100×). White arrows indicate neurite protrusions. d PC12 cells injury/death was quantified by LDH assay after 
8 h OGD. GUW showed concentration dependent protective effects on cells. e PC12 cells injury/death was quantified by measuring the release of 
LDH from injured cells. After OGD, single extracts of GE or UR only did not exhibit significant protective effect on OGD insult on NGF‑treated PC12 
cell. However, both GUW and the combination of GE and UR (GE + UR) water extracts have significant protective effects. Furthermore, GUW was 
also found to exert significantly greater neuroprotection better than GE + UR; vs control and vs OGD by one way ANOVA, post hoc Dunnett’s test 
(n = 4); vs GE + UR by Student’s t test (n = 4)
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Drug interaction of Gastrodia elata and Uncaria 
rhynchophylla
The individual GE and UR extracts (GE  +  UR) were 
mixed to form the same composition as that of GUW to 
investigate whether the protective effects of GUW were 
acting in an addictive or synergistic manner and study 
the pharmaceutical relationship between the two herbs in 
GUW. The GE- and UR-only treatments did not provide 
significant protection to the cells from the OGD insult 
(Fig. 3e). Both GUW (P < 0.001) and GE + UR (P < 0.001) 
significantly attenuated LDH release, while GUW exerted 
significantly greater neuroprotection than GE  +  UR 
(P =  0.018). The q value obtained in our study was 16, 
suggesting that the herbs in GUW were acting synergisti-
cally to protect the cells against OGD-induced cell death.
Caspase‑3 activity
Caspase-3 activity increased significantly by 160  % 
(P < 0.001) compared with the control cells after exposure 
to OGD for 8 h (Fig. 4). However, the caspase-3 activity 
of the OGD groups returned to normal levels (P < 0.001) 
after they were treated with GUW (2000 μg/mL).
mRNA expression after OGD
The mRNA expression levels of Bcl-2, PDI and Nrf-2 in 
the GUW group were 1.6-(P = 0.0130), 2.4-(P = 0.0279) 
and 1.5-fold (P = 0.0066) higher than those of the OGD 
group, whereas no significant changes were observed 
in these levels between the OGD and control groups 
(Fig.  5a). The expression of the housekeeping gene 
β-actin was measured to normalize the expression levels 
of the target genes.
Flow cytometry analysis of reactive oxygen species
OGD led to a 2.5-fold increase in the quantity of intra-
cellular ROS compared with the control group. However, 
we also observed a significant decrease of 40  % in the 
quantity of ROS in the GUW samples compared with the 
OGD group (P < 0.001; Fig. 5b).
Activity of antioxidant enzymes
The SOD activity of the NGF-treated PC12 cells exposed 
to OGD was 80  % lower than that of the control group 
(P  =  0.0174; Fig.  5c). The treatment of these cells with 
GUW led to a 40  % increase in SOD activity compared 
with the OGD group (P < 0.001). The GPx and catalase 
activities of the NGF-treated PC12 cells decreased fol-
lowing their exposure to OGD (P  <  0.001), whereas the 
treatment of these cells with GUW effectively restored 
their GPx activity (P  =  0.0385; Fig.  5d). The catalase 
activity of the NGF-treated PC12 cells increased sig-
nificantly by 35 % in the OGD group compared with the 
control group (P < 0.001) (Fig. 5e), but no significant dif-
ference was found in the catalase activity between the 
OGD and GUW treatment groups.
GUW reduced the infarct volume and improved the 
histological outcome after MCAO
The MCAO operation inflicted damage to different areas 
on the right hemisphere of the brain, including the cor-
tex, hippocampus and basal ganglia cortex (Fig.  6a). 
GUW treatment led to a significant reduction in the 
infarct volume of brain by 55.7 % (P < 0.001) compared 
with the control group at 7 days post-operation (Fig. 6b).
Cresyl violet staining of the coronal brain sections 
taken from the rats in the MCAO group showed a dra-
matic decrease in the size of the Nissl bodies, as well as 
an increase in the size of the intracellular space between 
them (Fig. 6c). Notably, the administration of GUW res-
cued the neurons in the infarct region and preserved the 
tissue structure.
GUW led to increased expression levels of Bcl‑2 and Nrf‑2
Immunohistochemistry was used to examine the expres-
sion levels of Bcl-2 and Nrf-2 7  days after MCAO. The 
results revealed increases in the expression levels of 
Bcl-2 (Fig.  6d) and Nrf-2 (Fig.  6e) at the penumbra of 
the MCAO group. Further increases in the expression 
levels of these two proteins were observed in the GUW 
treatment group, suggesting that GUW modulated the 
expression levels of Bcl-2 and Nrf-2 in vivo.
GUW resulted in improved neurological function 
after MCAO
The NDS of the rats was measured on a daily basis after 
2 h of ischemia and 24 h of reperfusion. The MCAO rats 
Fig. 4 Changes in caspase‑3 activity following OGD on NGF‑treated 
PC12 cells. The activity of caspase‑3 in the cell lysates were measured 
and normalized with the control group, vs OGD by one way ANOVA, 
post hoc Dunnett’s test (n = 4)
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Fig. 5 a mRNA expression levels of antioxidant and antiapoptotic genes after OGD and GUW treatment. Ct values of the genes of interest were first 
normalized to intrinsic β‑actin of each sample, then the fold differences among each group and control was them calculated, vs OGD by one way 
ANOVA, post hoc Dunnett’s test (n = 4). Status of oxidative stress after OGD and GUW treatment. b Reactive oxygen species amount in between the 
control, OGD and GUW ‑treated group. The concentration of intracellular ROS was analyzed by flow cytometry. c SOD, d GPx and e Catalase activity 
in NGF‑treated PC12 cells in different treatment groups, vs control and vs OGD by one way ANOVA, post hoc Dunnett’s test (n = 4)
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scored higher than 3. Notably, GUW treatment led to a 
lower score after day 3 compared with the MCAO con-
trol (P < 0.001; Fig. 7a).
GUW led to improved behavior in the Beam‑walking test 
after MCAO‑injury
The time taken for rats to walk across the beam was 
recorded daily. The MCAO control rats took 31 ± 21 to 
42  ±  33  s to walk along the wooden beam throughout 
the experimental period, which was fourfold higher than 
that of the sham group (P < 0.001). A significantly faster 
walking time was observed in the GUW-treated rats after 
3 days of drug treatment. For example, the time taken to 
cross the beam in this group decreased from 39 ± 27 s at 
day 1 to 11 ±  6  s at day 3 (P  <  0.001), resulting in per-
formance comparable with that of the sham group rats 
(Fig. 7b).
Discussion
In this study, we investigated the protective effects of 
GUW on NGF-treated PC12 cells subjected to OGD by 
measuring LDH release. GUW protected NGF-treated 
Fig. 6 GUW reduced brain infarction volume and improved histological outcome. Brains were harvested 7 days of post‑operation. The brains were 
sliced and performed TTC staining to evaluate the infarction volume and cresyl violet staining to examine the neuronal morphology at the infarct 
region. a The percentage of brain infarction of different groups of rats at 7 days of post‑operation. b Data are expressed as mean ± SD, vs MCAO 
control group by one‑way ANOVA (n = 10). c GUW increased the number of cells with normal neuronal morphology and decreased the number 
of shrunken and misshapen cells in cresyl violet–stained sections (magnification factor 400×). The Bcl‑2 and Nrf‑2 expression at the penumbra was 
examined by immunohistochemistry. GUW showed to upregulate both proteins in the penumbra. Representative images of the expression of d 
Bcl‑2 and e Nrf‑2. Scale bar 20 µm
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PC12 cells against OGD-induced cell death and exhibited 
dose-dependent neuroprotective effects. Moreover, the 
neuroprotection effects of GUW were greater than those 
of the individual GE and UR extracts. Flow cytometry 
results revealed that GUW led to a significant decrease 
in the amount of ROS, resulting in lower caspase-3 activ-
ity. Along with the increase observed in the regulation 
of Bcl-2 by RT-PCR, these findings suggest that GUW 
could prevent cells from undergoing apoptosis as a con-
sequence of ischemic insults.
Oxidative stress is one of the major contributors 
to the pathophysiological consequences observed in 
cerebral ischemia [36–38]. Oxidative stress also par-
ticipates in excitotoxic neuronal necrosis, leading to 
systemic oxidative damage and apoptosis [36, 39]. To 
determine whether GUW could modulate the antioxi-
dant protective mechanism in cells, we studied its effect 
on the activities of several antioxidant enzymes. Nrf-2 
is a basic leucine zipper redox-sensitive transcriptional 
factor that regulates the expression of several cellular 
antioxidant and cytoprotective genes from the ARE [7, 
40, 41]. The upregulation of Nrf-2 has been reported to 
mitigate oxidative stress-induced tissue injury in  vivo 
[10, 42]. In contrast, the overexpression of PDI may lead 
to increased resistance to hypoxic or ischemic injury 
in vitro and in vivo [43]. Moreover, PDI enhances chap-
erone activity to protect against oxidative stress injury, 
suggesting that PDI may participate in more than one 
mechanism to protect neuronal cells from ischemic 
injury [43, 44]. Cerebral ischemia led to decreases in 
GPx and SOD activity, as well as an increase in cata-
lase activity [45]. GUW rescued the expression of GPx 
and SOD activity, and had no discernible impact on the 
catalase activity. GUW could therefore modulate the 
Nrf-2-ARE pathway and enhance the antioxidant mech-
anism to protect the cells from ROS-induced oxidative 
damage.
Although most drugs show promising in vitro results, 
their application in  vivo has been limited by their poor 
blood–brain barrier permeability [46]. The active compo-
nents in GUW could penetrate the blood–brain barrier 
in vivo [47–49]. The in vivo efficacy of GUW was inves-
tigated using a MCAO model. Although it is not possible 
to rescue the neurons in the infarction core, the neurons 
in the penumbra region may be salvaged from ischemic/
reperfusion injury [50]. The results of our study showed 
a smaller infarct area after GUW treatment compared 
with the control animals, suggesting that GUW rescued 
the cells in the penumbra. The immunohistochemis-
try results showed an upregulation in the levels of Bcl-
2 and Nrf-2 at the penumbra in the GUW treatment 
group. This result was consistent with the in vitro results, 
which showed that GUW modulated the antiapoptotic 
and antioxidative genes to protect the brain from cer-
ebral ischemia. Notably, the treatment of the MCAO 
rats with GUW led to a reduction in their NDS, as well 
as a decrease in the time required to complete the beam-
walking test.
The results of our interaction study for GE and UR 
showed that GUW was a stronger neuroprotective agent 
than the GE + UR mixture, suggesting that GE and UR 
exhibit synergistic effects in GUW capable of supporting 
the survival of NGF-treated PC12 cells under OGD. It is 
therefore likely that the decocting process for the pro-
duction of GUW resulted in the formation of the active 
components responsible for the greater neuroprotec-
tive effect [51, 52]. This study therefore represents the 
first report to show that the combination of GE and UR 
might lead to synergistic effects. Further chemical analy-
sis is needed in the future to determine the root cause of 
this synergistic effect.
Fig. 7 Sprague Dawley rats showed recovery of neurological and 
locomotor function after receiving GUW treatment. a Daily neuro‑
logical deficit score measurement of different groups. Neurological 
deficit score was measured and recorded on day 1, 3, 5, 7 after MCAO 
surgery. MCAO control group received distilled water as vehicle. Data 
are expressed as mean ± SD, vs control group by one way ANOVA 
(n = 10). b Results of beam walking test after brain injury. After MCAO 
operation, rats receiving either vehicle or GUW showed significantly 
longer latencies to across the beam compared to sham‑injured rats. 
At first 3 days treatment, the time to cross beam of GUW group was 
shorter time than the MCAO group significantly. Data are expressed 
as mean ± SD, vs sham group and vs MCAO group, by one way 
ANOVA (n = 10)
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Conclusion
GUW modulated the antioxidant system and antia-
poptotic genes in neuronal differentiated PC12 cells at 
2000  g/mL following oxygen-glucose deprivation and 
Sprague–Dawley rats at 288.6  mg/kg following middle 
cerebral artery occlusion.
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